跳至主要内容
临床试验/IRCT20230920059483N1
IRCT20230920059483N1已完成2 期

Comparison between neostigmine and atropine added to standard post-dural puncture headache regimen versus standard regimen alone

Combined Military Hospital Kharian, Pakistan0 个研究点目标入组 130 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 35 years(—)
性别
Female

入选标准

  • Included all patients with post-dural puncture headache diagnosed according to the International Headache Society Criteria, presenting to the anesthesia clinic 48-72 hours after caesarian delivery.

排除标准

  • Patients unwilling for IV or oral therapy
  • Refusal to be included in the study
  • Patients with allergy to either atropine, neostigmine, paracetamol and/or ibuprofen
  • Patients with known history of migraine, cluster headache, patients on anti-depressants
  • Patients with any neurological disease and patients with major respiratory and cardiac disease.

研究者

发起方
Combined Military Hospital Kharian, Pakistan

相似试验